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Introduction
The existence of cancer stem cells is a hypothesis put forth both to explain the initiation of cancer and the recurrence of cancer after treatment. Evidence supporting the presence of cancer stem cells has been developed both in hematologic malignancies and solid tumors. In breast cancer, CD44 + /CD24 -/low tumorigenic stem cells have been identified with as few as 100 cells being able to form tumors in mice [1, 2] . These cells exhibit unlimited propagation and could give rise to subpopulations of tumorigenic and nontumorigenic cells. These CD44 positive cells expressed many known stem cell markers and presence of CD44 + /CD24
-/low cells correlated with the survival of breast cancer patients [3] . In addition to breast cancer tissue, cancer stem cell-like cells were also found in carcinoma-derived cell lines [4, 5] . cancer stem-like cell and mammary progenitor cells to radiation [6, 7] . 
Key Research Accomplishments:
In 
Reportable Outcomes
Currently no reportable Outcome. The differential radiation resistance among the subpopulation might not rely on the NHEJ activity.
Conclusions
Differential activation of ATM/ ATR pathway may contribute to differential radiation resistance among the subpopulations of breast cancer cell lines. Therefore, if NHEJ pathway is further demonstrated not to be responsible for differential radiation resistance among the subpopulations we suggest switching the focus of the study to the radiation-induced activation of the ATM/ATR pathway and identify the ATM/ATR associated proteins after radiation.
1.3%
0.4% 0.6% 0% 0% 0.1% MCF-7 cells were sorted by CD44 and CD24 as CD44 + /CD24 low and CD44 -/CD24 high subpopulations After 2 week of culture, cells were exposed to radiation at 2 Gy. Cologenic survival analysis was conducted and survival fraction at 2 Gy was calculated as described in Figure 6 . Each column represents mean of three independent experiments + SD. Note: There were not enough MCF-7 cells to isolated nuclear extract after sorting.
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